Pharma Business - April 25, 2022
Pila Pharma applies for Orphan Drug Designation in the US
The company has submitted a request for an Orphan Drug Designation to the U.S. Food and Drug Administration (FDA) for the company’s development candidate XEN-D0501. The aim is to develop a novel treatment of a rare disease associated with pain due to neurogenic inflammation. “I’m really pleased, that we can now publically share what we […]
Nobel Prize Discoveries - April 24, 2022
Unlocking the door to a complex sense
The Nobel Laureates in Medicine 2021 revealed the mechanisms that underpin the different sensations of temperature and touch. Their discoveries have led to a better understanding of how the nervous system codes sensory information, as well as triggering a myriad of exciting new questions.
In a new job - February 10, 2022
Pila Pharma announces changes to its organization
Scientific Advisor Henning Beck Nielsen, as well as COO Lars B. Rasmussen have both decided to step out of their current PILA roles to focus more on other projects outside the company. “I, sincerely, thank them both for their tremendous contribution in developing PILA to its current stage. Together with Henning Beck-Nielsen we laid out […]
Uncategorized - October 7, 2021
PILA Pharma’s leading principle awarded with a Nobel Prize
One of the receptors discovered by the Nobel Laureates in Medicine is the TRPV1 receptor, which is used by PILA as the leading principle for a novel treatment of diabetes. The 2021 Nobel prize in Physiology or Medicine honors discoveries of receptors for temperature and touch. One of these receptors, the TRPV1 receptor, is thanks […]
Agreement - August 10, 2021
Pila Pharma signs manufacturing agreement
Pila Pharma has signed a manufacturing agreement with Almac Sciences Limited, UK, for the production of XEN-D0501 active pharmaceutical ingredient (API). The availability of new API is key for conducting the planned 3 month toxicology studies, that are in turn a prerequisite for initiating the clinical phase 2b study in type-2 diabetics, states the company […]
In a new job - May 26, 2021
Pila Pharma announces management changes
The company has announced adjustment to the management team and the appointment of a new Chairman of the Board to prepare for coming upscaling of the company. “I am pleased to share the information that we have promoted Lars Bukhave Rasmussen, to become Chief Operating Officer (COO). Further, I’m proud to announce the appointment of […]
